<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5576331</article-id><article-id pub-id-type="publisher-id">2124</article-id><article-id pub-id-type="doi">10.1186/s13063-017-2124-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7106-7742</contrib-id><name><surname>Geidl</surname><given-names>Wolfgang</given-names></name><address><email>wolfgang.geidl@fau.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Semrau</surname><given-names>Jana</given-names></name><address><email>jana.semrau@fau.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Streber</surname><given-names>René</given-names></name><address><email>rene.streber@fau.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lehbert</surname><given-names>Nicola</given-names></name><address><email>Nicola.lehbert@klinik-bad-reichenhall.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wingart</surname><given-names>Silke</given-names></name><address><email>silke.wingart@klinik-bad-reichenhall.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tallner</surname><given-names>Alexander</given-names></name><address><email>alexander.tallner@medday-pharma.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wittmann</surname><given-names>Michael</given-names></name><address><email>michael.wittmann@klinik-bad-reichenhall.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Rupert</given-names></name><address><email>rupert.wagner@klinik-bad-reichenhall.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schultz</surname><given-names>Konrad</given-names></name><address><email>konrad.schultz@klinik-bad-reichenhall.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pfeifer</surname><given-names>Klaus</given-names></name><address><email>klaus.pfeifer@fau.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Institute of Sport Science and Sport, Friedrich-Alexander University Erlangen-Nürnberg, </institution></institution-wrap>Gebbertstr. 123b, 91058 Erlangen, Germany </aff><aff id="Aff2"><label>2</label>Klinik Bad Reichenhall, Centre for Rehabilitation, Pulmonology and Orthopaedics, Salzburger Straße 8-11, 83435 Bad Reichenhall, Germany </aff><aff id="Aff3"><label>3</label>MedDay Pharmaceuticals GmbH, Münsterstraße 5, 59065 Hamm, Germany </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>18</volume><elocation-id>396</elocation-id><history><date date-type="received"><day>7</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><text><SENT sid="1" pm="."><plain>Background </plain></SENT>
</text></title><p id="Par1"><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Pulmonary rehabilitation programs often fail to substantially enhance long-term physical activity in patients with chronic obstructive pulmonary disease (COPD). </plain></SENT>
<SENT sid="3" pm="."><plain>The reasons for successful physical activity changes in patients with COPD are not well understood. </plain></SENT>
<SENT sid="4" pm="."><plain>The need to better understand the determinants of physical activity in patients with COPD and effective rehabilitation strategies to improve physical activity is evident. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="5" pm="."><plain>Methods/design </plain></SENT>
</text></title><p id="Par2"><SecTag type="ABS"><text><SENT sid="6" pm="."><plain>The STAR study (Stay Active after Rehabilitation) investigates, in a randomized controlled trial, the additional effect of a pedometer-based behavior-change intervention during inpatient pulmonary rehabilitation on objectively measured physical activity 6 weeks and 6 months post rehabilitation. </plain></SENT>
<SENT sid="7" pm="."><plain>The intervention uses the behavior-change techniques (1) instruction on how, where and when to perform the behavior, (2) prompt goal setting for physical activity, (3) prompt self-monitoring of behavior, and (4) feedback on behavior. </plain></SENT>
<SENT sid="8" pm="."><plain>The primary outcome of physical activity will be measured using a physical activity monitor (Actigraph wGT3X-BT) for a period of 7 days, firstly 2 weeks before rehabilitation begins (t0) as well as 6 weeks and 6 months after rehabilitation (t3, t4). </plain></SENT>
<SENT sid="9" pm="."><plain>Additionally, to predict physical activity progression after rehabilitation, a complex personal diagnostics battery, including questionnaires as well as functional assessments, is to be carried out at the start and end of rehabilitation (t1, t2). </plain></SENT>
<SENT sid="10" pm="."><plain>This battery is based on the foundational ideas of the Physical Activity-Related health Competence model. </plain></SENT>
</text></SecTag></p><p id="Par3"><SecTag type="ABS"><text><SENT sid="11" pm="."><plain>Five hundred and two patients with COPD, aged 18 years or older and admitted for an approved pulmonary rehabilitation, will be enrolled in the STAR study. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="12" pm="."><plain>Discussion </plain></SENT>
</text></title><p id="Par4"><SecTag type="ABS"><text><SENT sid="13" pm="."><plain>The STAR study is designed as a randomized controlled trial to gain a better understanding of the personal determinants of physical activity in patients with COPD and to evaluate a pedometer-based physical activity-change intervention in the context of inpatient pulmonary rehabilitation. </plain></SENT>
<SENT sid="14" pm="."><plain>The results enable the future identification of patients with COPD who will find it difficult to engage in long-term physical activity after rehabilitation. </plain></SENT>
<SENT sid="15" pm="."><plain>Based on this, intervention strategies to promote physical activity in the content of pulmonary rehabilitation can be optimized. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="16" pm="."><plain>Trial registration </plain></SENT>
</text></title><p id="Par5"><SecTag type="ABS"><text><SENT sid="17" pm="."><plain>Clinicaltrials.gov, ID: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02966561">NCT02966561</ext-link>. </plain></SENT>
<SENT sid="18" pm="."><plain>Registered retrospectively after the start of the recruitment in June 2016 on 22 November 2016. </plain></SENT>
<SENT sid="19" pm="."><plain>All protocol modifications will be registered in the trial registry. </plain></SENT>
</text></SecTag></p></sec><sec><title><text><SENT sid="20" pm="."><plain>Electronic supplementary material </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="21" pm="."><plain>The online version of this article (doi:10.1186/s13063-017-2124-z) contains supplementary material, which is available to authorized users. </plain></SENT>
</text></SecTag></p></sec></abstract><SecTag type="KEYWORD"><kwd-group xml:lang="en"><title>Keywords</title><kwd>Behavior-change intervention</kwd><kwd>Chronic obstructive pulmonary disease (COPD)</kwd><kwd>Implicit association test</kwd><kwd>Pedometer</kwd><kwd>Accelerometry</kwd><kwd>Physical activity-related health competence</kwd><kwd>Health-related quality of life (HRQoL)</kwd></kwd-group></SecTag><funding-group><award-group><funding-source><institution>German Pension Insurance Association, Section Bavaria South</institution></funding-source><award-id>5.011-6.031.115</award-id><principal-award-recipient><name><surname>Geidl</surname><given-names>Wolfgang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec id="Sec1" sec-type="introduction"><title><text><SENT sid="22" pm="."><plain>Background </plain></SENT>
</text></title><p id="Par14"><text><SENT sid="23" pm="."><plain>The initiation of a physically active lifestyle is a central goal of pulmonary rehabilitation (PR) [1]; though in patients with chronic obstructive pulmonary disease (COPD), PR programs often fail to substantially enhance long-term physical activity (PA) [2–4]. </plain></SENT>
<SENT sid="24" pm="."><plain>The reasons for successful PA behavior changes in patients with COPD are not well understood [5]. </plain></SENT>
<SENT sid="25" pm="."><plain>The role of psychological factors especially, and their interplay with physical functioning needs further investigation [6]. </plain></SENT>
<SENT sid="26" pm="."><plain>Consequently, following Spruit et al. [4], two aspects are needed for optimized patient treatment during PR: (1) a better understanding of the determinants of PA in patients with COPD and (2) effective strategies to improve important determinants and, accordingly, PA. </plain></SENT>
</text></p><p id="Par15"><text><SENT sid="27" pm="."><plain>In covering the first point, the concept of Physical Activity-related health Competence (the PARC model) provides a new model to describe personal determinants of PA [7]. </plain></SENT>
<SENT sid="28" pm="."><plain>The PARC model focuses on personal competencies that favor the integration of PA in everyday life. </plain></SENT>
<SENT sid="29" pm="."><plain>The model’s three components are movement competence, control competence, and self-regulation competence. </plain></SENT>
<SENT sid="30" pm="."><plain>These subcompetencies are directly linked to the requirements for initiating and maintaining PA with positive effects on health and wellbeing. </plain></SENT>
<SENT sid="31" pm="."><plain>In comparison to other health psychology models of health behavior, the competence-based perspective of the PARC model is considered to add value because it contains movement-related, task-specific as well as sport-typical elements. </plain></SENT>
<SENT sid="32" pm="."><plain>Notably, the PARC model incorporates important individual physical and psychological characteristics. </plain></SENT>
<SENT sid="33" pm="."><plain>This is especially important for the explanation of PA behavior of older adults and clinical populations. </plain></SENT>
<SENT sid="34" pm="."><plain>The first validated, generic questionnaire for the subcompetencies of the PARC model is now available [7]. </plain></SENT>
<SENT sid="35" pm="."><plain>For clinical populations, this questionnaire could profit from an extension with indication-specific characteristics (e.g., obstructive lung function for patients with COPD), allowing for a complex and adequate assessment of individual determinants of PA in clinical populations. </plain></SENT>
</text></p><p id="Par16"><text><SENT sid="36" pm="."><plain>With regard to the second point, the use of pedometers ranks as one of the most effective intervention elements for PA promotion [8]. </plain></SENT>
<SENT sid="37" pm="."><plain>Pedometers offer various possibilities to design behavior-change strategies [9]. </plain></SENT>
<SENT sid="38" pm="."><plain>In particular, pedometers are of use for persons to monitor and record their daily PA. </plain></SENT>
<SENT sid="39" pm="."><plain>Self-monitoring of behavior has been proven to be one of the most effective behavior-change techniques (BCT) in clinical populations [10]. </plain></SENT>
<SENT sid="40" pm="."><plain>Furthermore, pedometers are suitable in support of other BCT [11], e.g., individual goal setting in the unit steps per day or giving feedback on behavior. </plain></SENT>
<SENT sid="41" pm="."><plain>In nonclinical populations, pedometer-based interventions achieve an average increased PA level of approximately 2000 steps per day (effect size d = 0.68) in comparison to control groups [12]. </plain></SENT>
<SENT sid="42" pm="."><plain>Clinical populations provide preliminary evidence for the effectiveness of pedometers as part of rehabilitation for people with musculoskeletal disease [13], type-2 diabetes [14] as well as COPD [15, 16]. </plain></SENT>
<SENT sid="43" pm="."><plain>However, these results come from studies with small sample sizes in outpatient rehabilitation programs. </plain></SENT>
<SENT sid="44" pm="."><plain>Moreover, these studies often relate to short-term behavior changes during the rehabilitation period. </plain></SENT>
<SENT sid="45" pm="."><plain>The validity of most studies is further restricted by the usage of PA questionnaires instead of objective PA measurements [4]. </plain></SENT>
<SENT sid="46" pm="."><plain>Singh et al. [17] summarized that pedometer studies’ sample sizes in PR were not, up to this point, suitable for the detection of meaningful differences in PA levels. </plain></SENT>
<SENT sid="47" pm="."><plain>In the context of inpatient PR the potential of pedometers to first initiate and afterward maintain a physically active lifestyle in the long term has not yet been investigated. </plain></SENT>
</text></p><p id="Par17"><text><SENT sid="48" pm="."><plain>The purpose of this paper is to describe the design of a randomized controlled trial (RCT) to (1) evaluate the effect of a short, pedometer-based behavior-change intervention (BCI) for inpatient PR in COPD patients with regard to the initiation (6-week follow-up) and maintenance (6-month follow-up) of a physically active lifestyle after PR and (2) to predict the expected intervention treatment effect and PA progression after PR discharge utilizing an innovative diagnostic battery that is based on the PARC model [7]. </plain></SENT>
</text></p><p id="Par18"><text><SENT sid="49" pm="."><plain>The STAR study (Stay Active after Rehabilitation) aims to answer two central questions: does the integration of a pedometer-based intervention during inpatient PR for people with COPD, in comparison to standard PR, lead to a sustained improvement of PR results with regards to PA 6 weeks and 6 months after the PR? how does PA-related health competence of individuals with COPD develop during inpatient PR; and which individual PA-related health competence characteristics, in combination with which disease-specific prognostic assessments, enable the prediction of the expected intervention treatment effect as well as of the initiation and long-term maintenance of a physically active lifestyle after PR? </plain></SENT>
</text></p><sec id="Sec2"><title><text><SENT sid="50" pm="."><plain>Hypothesis </plain></SENT>
</text></title><sec id="Sec3"><title><text><SENT sid="51" pm="."><plain>Primary hypothesis </plain></SENT>
</text></title><p id="Par21"><text><SENT sid="52" pm="."><plain>In individuals with COPD, inpatient PR (= standard care) plus a pedometer-based BCI will result in a significantly higher level of PA 6 weeks and 6 months after rehabilitation compared to standard care plus a short revision of patient education. </plain></SENT>
</text></p></sec><sec id="Sec4"><title><text><SENT sid="53" pm="."><plain>Secondary hypothesis </plain></SENT>
</text></title><p id="Par22"><text><SENT sid="54" pm="."><plain>The secondary outcomes (PA-related health competence of patients with COPD in combination with other PA behavior-related psychological measurements and disease-specific prognostic assessment) will enable the explanation of the treatment effect and the prediction of PA progression after PR discharge. </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="METHODS"><sec id="Sec5"><title><text><SENT sid="55" pm="."><plain>Methods/design </plain></SENT>
</text></title><sec id="Sec6"><title><text><SENT sid="56" pm="."><plain>Study design </plain></SENT>
</text></title><p id="Par23"><text><SENT sid="57" pm="."><plain>The study will be conducted using a randomized controlled intervention design with five measurement time points (t0–t4; see Fig. 1).Fig. 1Study flow chart of subjects </plain></SENT>
</text></p></sec><sec id="Sec7"><title><text><SENT sid="58" pm="."><plain>Study population </plain></SENT>
</text></title><p id="Par24"><text><SENT sid="59" pm="."><plain>The study will take place within the German rehabilitation system which typically provides an inpatient rehabilitation in a disease-specific rehabilitation clinic for a duration of 3 weeks. </plain></SENT>
<SENT sid="60" pm="."><plain>Eligible are patients with COPD in all 2011 GOLD classifications A–D [18] and stages 1–4 who are enrolled for PR with the rehabilitation clinic Bad Reichenhall, the largest PR clinic in Germany. </plain></SENT>
<SENT sid="61" pm="."><plain>Recruitment starts in June 2016 and is likely to be finished in September 2017. </plain></SENT>
</text></p><p id="Par25"><text><SENT sid="62" pm="."><plain>Table 1 provides an overview of all inclusion and exclusion criteria. </plain></SENT>
<SENT sid="63" pm="."><plain>The study nurse verifies inclusion criteria based on the written information available from the general practitioner who filed the application for PR. </plain></SENT>
<SENT sid="64" pm="."><plain>At the start of PR the admitting physician confirms the inclusion and exclusion criteria during the initial examination.Table 1Study inclusion and exclusion criteriaInclusion criteria (ICD-10)Main diagnosis for the pulmonary rehabilitation: physician-confirmed diagnosis of chronic obstructive pulmonary disease (COPD) (International classification code: J44.- at all 2011 GOLD classifications A–D). </plain></SENT>
<SENT sid="65" pm="."><plain>The diagnosis has to be confirmed in each case by lung function (FEV1/VC &lt; 0.7 after bronchospasmolysis) and a respiratory specialist at admission to the pulmonary rehabilitation clinicAge ≥ 18 yearsExclusion criteriaSevere comorbidities, which will affect the results of the outcome parameters much more than pulmonary rehabilitation; for example, cancer or severe cardiac or neurological comorbiditiesConsiderable reduction of sight and hearingSevere psychiatric condition as a secondary diagnosisLack of ability to speak German ICD-10 International Classification of Diseases, version 10 </plain></SENT>
</text></p></sec><sec id="Sec8"><title><text><SENT sid="66" pm="."><plain>Study flow and recruitment procedures </plain></SENT>
</text></title><p id="Par26"><text><SENT sid="67" pm="."><plain>This study consists of two phases (see Fig. 2). </plain></SENT>
<SENT sid="68" pm="."><plain>Phase I consists of the measurement point t0 2 weeks before the start of inpatient PR. </plain></SENT>
<SENT sid="69" pm="."><plain>Subjects in study phase I are asked to participate in phase II (t1–t4) upon arrival for PR.Fig. 2Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT) figure [37–57] </plain></SENT>
</text></p><p id="Par27"><text><SENT sid="70" pm="."><plain>Six weeks before the start of PR, eligible subjects will be contacted in writing by the PR clinic study nurse. </plain></SENT>
<SENT sid="71" pm="."><plain>The letter contains detailed information about the process of study phase I. </plain></SENT>
<SENT sid="72" pm="."><plain>Furthermore, patients are asked for their consent to be contacted via telephone. </plain></SENT>
<SENT sid="73" pm="."><plain>Persons who agree will be called by the study nurse, provided with further information about the study and asked to participate in study phase I. </plain></SENT>
<SENT sid="74" pm="."><plain>Participants return written informed consent via a prepaid envelope. </plain></SENT>
<SENT sid="75" pm="."><plain>This form provides the necessary consent for participation in the t0 measurement. </plain></SENT>
<SENT sid="76" pm="."><plain>The PA monitor will then be shipped out from the Erlangen study center. </plain></SENT>
<SENT sid="77" pm="."><plain>Enclosed along with the PA monitor, participants receive precise, illustrated instructions for wearing the PA monitor. </plain></SENT>
<SENT sid="78" pm="."><plain>Additional telephone support will be available from the Erlangen study center for all questions regarding study phase I, including any accelerometer issues. </plain></SENT>
</text></p><p id="Par28"><text><SENT sid="79" pm="."><plain>Study phase II starts with the beginning of inpatient PR. </plain></SENT>
<SENT sid="80" pm="."><plain>During initial PR admission assessment subjects of study phase I will be informed about the course of the study phase II (t1–t4). </plain></SENT>
<SENT sid="81" pm="."><plain>A second signed informed consent is required for participation in phase II of the study. </plain></SENT>
<SENT sid="82" pm="."><plain>Subjects will then be randomized into two study arms, either the control group (CG) or the intervention group (IG). </plain></SENT>
<SENT sid="83" pm="."><plain>All subjects will first undergo an initial assessment of PA-related health competence (t1). </plain></SENT>
<SENT sid="84" pm="."><plain>Before the start of the study interventions (see the “Interventions” section below) in week 2 of the inpatient PR, CG and IG will each receive a short introductory session explaining the use of PA monitors. </plain></SENT>
<SENT sid="85" pm="."><plain>At the end of the inpatient PR, the assessment battery from t1 will be repeated (t2). </plain></SENT>
</text></p><sec id="Sec9"><title><text><SENT sid="86" pm="."><plain>Follow-up phase </plain></SENT>
</text></title><p id="Par29"><text><SENT sid="87" pm="."><plain>The study center in Erlangen will contact subjects via letter 6 weeks (t3) and 6 months (t4) after discharge from the inpatient PR program. </plain></SENT>
<SENT sid="88" pm="."><plain>Provided that participant’s current health status along with any other considerations (e.g., holidays) do not preclude wearing the PA monitor, the device and follow-up questionnaires will be sent to the subjects for t3-PA and t4-PA measurement. </plain></SENT>
<SENT sid="89" pm="."><plain>If the PA monitor and the questionnaire has not been returned within 2 weeks, postal reminders will be sent. </plain></SENT>
</text></p></sec><sec id="Sec10"><title><text><SENT sid="90" pm="."><plain>Dropout criteria </plain></SENT>
</text></title><p id="Par30"><text><SENT sid="91" pm="."><plain>This study recruits patients with COPD assigned to PR. </plain></SENT>
<SENT sid="92" pm="."><plain>In some cases, after the physical examination in the rehabilitation clinic, initial diagnoses are proven incorrect after already having completed the t0 measurement at home. </plain></SENT>
<SENT sid="93" pm="."><plain>These cases are not classified as dropouts but as being falsely included initially. </plain></SENT>
<SENT sid="94" pm="."><plain>Dropouts for study phase I are defined as patients who provided an informed consent for phase I but refused to complete the baseline evaluation (t0). </plain></SENT>
<SENT sid="95" pm="."><plain>Dropouts for study phase II are defined as patients who provided an informed consent for phase II but refused to complete one or more of the following measurements (t1–t4). </plain></SENT>
<SENT sid="96" pm="."><plain>Additionally, dropouts are classified as patients who withdraw from the study during phase I or phase II and prohibit the use of existing data. </plain></SENT>
<SENT sid="97" pm="."><plain>Subjects who did not complete treatment, or who did not complete assessment at the end of the inpatient PR but do not explicitly refuse or withdraw from the study, will be followed up. </plain></SENT>
<SENT sid="98" pm="."><plain>Figure 1 illustrates the flow chart of study subjects. </plain></SENT>
</text></p></sec><sec id="Sec11"><title><text><SENT sid="99" pm="."><plain>Registration of nonresponders </plain></SENT>
</text></title><p id="Par31"><text><SENT sid="100" pm="."><plain>The registration of all eligible patients and the reporting of the number and sex of eligible patients who do not participate in the study will take place for both study phase I and study phase II. </plain></SENT>
</text></p></sec></sec><sec id="Sec12"><title><text><SENT sid="101" pm="."><plain>Randomization </plain></SENT>
</text></title><p id="Par32"><text><SENT sid="102" pm="."><plain>The randomization of subjects in study phase II is carried out by a study nurse after initial physical examination using an externally provided randomization list from the Friedrich-Alexander-Universität Erlangen-Nürnberg. </plain></SENT>
<SENT sid="103" pm="."><plain>Randomization is stratified based on the four prognostic dichotomous variables sex (male vs. female), progression of COPD (GOLD stages 1–2 vs. stages 3–4), age (&lt;60 years vs. ≥ 60 years), and type of rehabilitation (PR in patients with stable COPD vs. PR after hospitalization due to subsequent COPD-related airway obstruction). </plain></SENT>
<SENT sid="104" pm="."><plain>The randomization list is created in blocks with six subjects per block. </plain></SENT>
<SENT sid="105" pm="."><plain>The study nurse is aware of the allocation in the different strata. </plain></SENT>
<SENT sid="106" pm="."><plain>The randomization scheme was generated by using the website Randomization.com. </plain></SENT>
</text></p></sec><sec id="Sec13"><title><text><SENT sid="107" pm="."><plain>Sample size and power calculation </plain></SENT>
</text></title><p id="Par33"><text><SENT sid="108" pm="."><plain>A consecutive sample of 351 PR patients is needed. </plain></SENT>
<SENT sid="109" pm="."><plain>Pedometer-based interventions are among the most effective intervention components to promote PA in everyday life [8]. </plain></SENT>
<SENT sid="110" pm="."><plain>Meta-analysis has shown, in comparison to control groups, an average mean effect size of 0.68 on PA which represents an increase of 2000 steps per day [12]. </plain></SENT>
<SENT sid="111" pm="."><plain>The long-term effect on PA of standard inpatient PR in people with COPD is assumed to be small [16]. </plain></SENT>
<SENT sid="112" pm="."><plain>In comparison to standard PR we expect a small effect (d = 0.3) at t4. </plain></SENT>
<SENT sid="113" pm="."><plain>The power calculation (by means of software G*Power 3.0) with respect to the primary target (analysis of covariance to t4, mean effect size of d = 0.3, an alpha error level of 5%, and statistical power of 80%) results in a required sample of at least 351 subjects with complete data. </plain></SENT>
<SENT sid="114" pm="."><plain>In a preliminary pilot study, a generally high willingness to participate of 96% was recorded. </plain></SENT>
<SENT sid="115" pm="."><plain>A dropout of 30% from baseline measurement t0 to t4 is estimated based on the pilot study. </plain></SENT>
<SENT sid="116" pm="."><plain>With this dropout rate, the recruitment of a total of 502 subjects (251 subjects per group) is necessary. </plain></SENT>
<SENT sid="117" pm="."><plain>The study sample size is adequate for the determination of PA predictors after rehabilitation and with a weekly average of 12 subjects and a conservative recruitment rate of 66%, the study aims should be reached within the recruiting period of 15 months. </plain></SENT>
</text></p></sec><sec id="Sec14"><title><text><SENT sid="118" pm="."><plain>Interventions </plain></SENT>
</text></title><sec id="Sec15"><title><text><SENT sid="119" pm="."><plain>Control arm </plain></SENT>
</text></title><p id="Par34"><text><SENT sid="120" pm="."><plain>The control group (CG) will receive standard PR. </plain></SENT>
<SENT sid="121" pm="."><plain>Standard PR is an intensive and comprehensive inpatient PR in a specialized German rehabilitation clinic. </plain></SENT>
<SENT sid="122" pm="."><plain>This PR is described in further detail below. </plain></SENT>
<SENT sid="123" pm="."><plain>In addition, the CG receives a “behavior placebo” intervention during their PR. </plain></SENT>
<SENT sid="124" pm="."><plain>This intervention contains playful PA and revisions of information on PA (knowledge on exercise recommendations, knowledge on possibilities of self-regulation of endurance training exercise intensity) obtained earlier during patient education of the standard PR. </plain></SENT>
<SENT sid="125" pm="."><plain>Similar to the IG subjects, the CG receive a booklet that looks identical to the PA diary used in the IG. </plain></SENT>
<SENT sid="126" pm="."><plain>This booklet contains a repetition of PA-related information from the standard PR curriculum. </plain></SENT>
</text></p><p id="Par35"><text><SENT sid="127" pm="."><plain>PR in the Bad Reichenhall Clinic. </plain></SENT>
<SENT sid="128" pm="."><plain>In Germany, PR is usually carried out as inpatient rehabilitation and generally lasts 3 weeks, an extension of 1 to 2 weeks is possible if necessary. </plain></SENT>
<SENT sid="129" pm="."><plain>PR is a comprehensive, multidisciplinary intervention based on an initial assessment followed by a combination of patient-tailored therapies [1, 19]. </plain></SENT>
<SENT sid="130" pm="."><plain>In the Bad Reichenhall Clinic PR lasts an average of 25 days, is tailored to the patients’ individual needs and includes the following obligatory main components: checking and, if required, adjusting the current COPD medication according to COPD guidelines; physical exercise (4–5 units/week of endurance exercise (45 min) and 3 units/week of strength exercise (45 min) per week, and 7 units/week whole-body vibration muscle training); structured COPD patient education (6 h of patient education COPD + 1 h inhaler device training), respiratory physiotherapy in groups (pursed lips breathing and other breathing and coughing techniques (2 units/week of 45 min)). </plain></SENT>
<SENT sid="131" pm="."><plain>Optional components include a comprehensive smoking-cessation program (at least 8 units), mucolytic physiotherapy, inspiratory muscle training (IMT), neuromuscular electrostimulation (NMES), saline inhalation therapy, psychological interventions and social counseling (individual and groups), nutritional counseling, patient education concerning long-term oxygen therapy, and occupational therapy including counseling on assistive devices. </plain></SENT>
<SENT sid="132" pm="."><plain>PR in Bad Reichenhall Clinic is implemented by an interdisciplinary rehabilitation team including experienced pneumologists who bear overall responsibility and coordinate the program along with further health professionals including physiotherapists, exercise therapists, occupational therapists, psychologists, social workers, nurses and nutritionists. </plain></SENT>
</text></p><p id="Par36"><text><SENT sid="133" pm="."><plain>For all patients – IC and CG – receiving PR in the Bad Reichenhall Clinic, treatment includes several intervention components addressing the promotion of PA. </plain></SENT>
<SENT sid="134" pm="."><plain>Additional file 1 lists the behavior-change techniques (BCT) included in standard care in the Bad Reichenhall Clinic according to the taxonomy of BCT from Michie et al. [11]. </plain></SENT>
</text></p></sec><sec id="Sec16"><title><text><SENT sid="135" pm="."><plain>Intervention arm </plain></SENT>
</text></title><p id="Par37"><text><SENT sid="136" pm="."><plain>Subjects in the intervention arm will receive the same standard inpatient PR program as the control arm. </plain></SENT>
<SENT sid="137" pm="."><plain>Instead of the placebo intervention of the CG the IG will additionally receive a pedometer-based PA BCI. </plain></SENT>
</text></p><p id="Par38"><text><SENT sid="138" pm="."><plain>The central components of the BCI include the following behavior-change techniques (BCT):Instruction on how, where and when to perform the behaviorPrompt goal setting for PAPrompt self-monitoring of behaviorFeedback on behavior </plain></SENT>
</text></p><p id="Par43"><text><SENT sid="139" pm="."><plain>The BCI integrates the most frequently applied BCT for PA promotion in patients with COPD [20]. </plain></SENT>
<SENT sid="140" pm="."><plain>Additional file 2 explicates the sequence of the two BCI lessons and defines the used BCT with regard to the BCT taxonomy [11]. </plain></SENT>
</text></p><p id="Par44"><text><SENT sid="141" pm="."><plain>The BCI will consist of two 45-min sessions. </plain></SENT>
<SENT sid="142" pm="."><plain>The first lesson is placed in the end of the second week of PR and the second lesson will take place in the middle of the third week of PR. </plain></SENT>
<SENT sid="143" pm="."><plain>During lesson 1 of the BCI, subjects receive a pedometer and booklet containing a PA diary and PA-related information (recommendations for exercise and PA for patients with COPD). </plain></SENT>
<SENT sid="144" pm="."><plain>Subjects keep the pedometer and the booklet after their PR discharge. </plain></SENT>
<SENT sid="145" pm="."><plain>The intervention replaces standard exercise therapy and for this reason the total amount of therapy is identical. </plain></SENT>
<SENT sid="146" pm="."><plain>The BCI is delivered in open groups (varying composition of subjects possible) with six to 12 patients. </plain></SENT>
<SENT sid="147" pm="."><plain>An exercise therapist from the clinic will hold both lessons. </plain></SENT>
<SENT sid="148" pm="."><plain>As BCT included in the sessions relate to PA, the lessons take place in a gymnasium. </plain></SENT>
</text></p><p id="Par45"><text><SENT sid="149" pm="."><plain>With regard to session length, placement (2 × 45 min in weeks 2 and 3 of the PR) and group composition, the CG lessons are identical to the IG. </plain></SENT>
</text></p></sec></sec><sec id="Sec17"><title><text><SENT sid="150" pm="."><plain>Outcome assessment </plain></SENT>
</text></title><sec id="Sec18"><title><text><SENT sid="151" pm="."><plain>Primary outcome measures </plain></SENT>
</text></title><p id="Par46"><text><SENT sid="152" pm="."><plain>The primary outcome is objectively measured PA at 6 weeks (t3) and 6 months (t4) after PR. </plain></SENT>
<SENT sid="153" pm="."><plain>Baseline measurement of PA is conducted 2 weeks before the inpatient PR begins (T0). </plain></SENT>
<SENT sid="154" pm="."><plain>PA is measured on seven consecutive days with a three-axial accelerometer PA monitor (Actigraph wGT3X-BT). </plain></SENT>
<SENT sid="155" pm="."><plain>This activity monitor is the one of the most accurate devices for COPD patients and is explicitly recommended as a valid tool to measure PA in this clinical population [21–23]. </plain></SENT>
</text></p></sec><sec id="Sec19"><title><text><SENT sid="156" pm="."><plain>Secondary outcome measures </plain></SENT>
</text></title><p id="Par47"><text><SENT sid="157" pm="."><plain>Secondary outcome measures will assess central psychological and physical functional determinants of long-term health-promoting PA applicable to patients following PR. </plain></SENT>
<SENT sid="158" pm="."><plain>As defined by the PARC model [24] the following characteristics will be collected: physical motor functions and consequences of health problems in functioning (physical function and disease-related impairments in activities and participation), motivation and volition, sports-related goals and motives, stage of behavior change, as well as characteristics of health and wellbeing. </plain></SENT>
<SENT sid="159" pm="."><plain>Data will be entered and stored at the Erlangen Study Center. </plain></SENT>
<SENT sid="160" pm="."><plain>Outcomes of the study and time frames for their collection are shown in Fig. 2. </plain></SENT>
</text></p></sec></sec><sec id="Sec20"><title><text><SENT sid="161" pm="."><plain>Data analysis </plain></SENT>
</text></title><sec id="Sec21"><title><text><SENT sid="162" pm="."><plain>Statistical analysis and evaluation </plain></SENT>
</text></title><p id="Par48"><text><SENT sid="163" pm="."><plain>Regarding the primary objective, a baseline-controlled comparison (covariance) of the post values between the initial assigned control and the intervention treatment group (intention-to-treat analysis) at the time points t3 and t4 will be provided for statistical analysis. </plain></SENT>
</text></p><p id="Par49"><text><SENT sid="164" pm="."><plain>For the secondary objective a cluster-based analysis method will be used for longitudinal records (e.g., linking of clusters after removal of a residue (LICUR); [25]). </plain></SENT>
<SENT sid="165" pm="."><plain>In this case the analysis creates separate clusters for each measurement using the comprehensive assessment battery for t1 and t2 and especially using the accelerometer PA data for t0, t3 and t4. </plain></SENT>
<SENT sid="166" pm="."><plain>The second step of the cluster-based analysis links separately created clusters in a longitudinal way. </plain></SENT>
</text></p><p id="Par50"><text><SENT sid="167" pm="."><plain>A strategy for dealing with missing data will be developed in cooperation with a biostatistician. </plain></SENT>
<SENT sid="168" pm="."><plain>If adequate and realistic, missing data will be substituted by multiple imputation. </plain></SENT>
</text></p><p id="Par51"><text><SENT sid="169" pm="."><plain>The processing of PA monitoring data as the primary outcome will be conducted as follows: the PA monitor will be worn for seven consecutive days with a minimum of four valid days inclusive of a weekend day [26–28]. </plain></SENT>
<SENT sid="170" pm="."><plain>A day is considered valid if subjects wear the device for ten or more waking hours [26–28], where non-wear time is set at 60 min of zero counts of which up to 2 min may be within the 0–100 count range [28, 29]. </plain></SENT>
<SENT sid="171" pm="."><plain>Current research points towards avoiding the use of direct monitor outputs such as energy expenditure estimations due to issues with reliability [21, 30]. </plain></SENT>
<SENT sid="172" pm="."><plain>Consensus points towards the use of both sedentary and moderate to vigorous physical activity (MVPA) cutoff points where sedentary activity is seen as 0 to &gt; 100 counts per min [27, 29, 31, 32] and MVPA as &gt; 1952 counts per min [29]. </plain></SENT>
<SENT sid="173" pm="."><plain>While the use of the LFE filter to calculate steps is not recommended, it may be applicable during data analysis of cutoff points for older adults [33, 34]. </plain></SENT>
<SENT sid="174" pm="."><plain>Future work on defining cutoff points in clinical populations will be considered. </plain></SENT>
</text></p></sec></sec><sec id="Sec22"><title><text><SENT sid="175" pm="."><plain>Blinding </plain></SENT>
</text></title><p id="Par52"><text><SENT sid="176" pm="."><plain>Blinding of the therapists was not possible as they work in the same clinical team and are involved in the development of this study. </plain></SENT>
<SENT sid="177" pm="."><plain>Patients will be masked with regard to study group. </plain></SENT>
<SENT sid="178" pm="."><plain>They will be informed by staff and in the “informed consent” that the effectiveness of two exercise therapy programs will be compared and that both meet current scientific standards and are appropriate to improve health status. </plain></SENT>
<SENT sid="179" pm="."><plain>During the study period, patients are not informed as to whether they participate in the control or the intervention group. </plain></SENT>
<SENT sid="180" pm="."><plain>A research assistant not involved in the study process will perform the statistical data analysis. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="Sec23"><title><text><SENT sid="181" pm="."><plain>Discussion </plain></SENT>
</text></title><p id="Par53"><text><SENT sid="182" pm="."><plain>A better understanding of the determinants of PA in patients with COPD and effective PR strategies to improve PA is evident. </plain></SENT>
<SENT sid="183" pm="."><plain>The STAR study fills two gaps in the academic literature (1) it investigates the ability of PR to promote PA to patients with COPD in the long term and (2) it investigates COPD individuals’ personal determinants of (un-)successful PA changes. </plain></SENT>
</text></p><p id="Par54"><text><SENT sid="184" pm="."><plain>The RCT design allows the evaluation of a short, pedometer-based BCI for inpatient PR in COPD patients with regard to the initiation (6-week follow-up) and maintenance (6-month follow-up) of a physically active lifestyle after PR. </plain></SENT>
<SENT sid="185" pm="."><plain>The design is suitable to overcome restrictions in previous empirical findings due to several reasons: it contains an adequately powered sample size, objectively measures PA with a validated measurement tool, and collects baseline PA data before PR in study phase I as well as at the 6-month follow-up after PR (study phase II). </plain></SENT>
<SENT sid="186" pm="."><plain>The reason for the two-phased study design is not to overburden eligible participants during initial recruitment and thereby ensure higher participation rates. </plain></SENT>
<SENT sid="187" pm="."><plain>Adding an additional 12-month follow-up would detect enduring effects on PA thereby further strengthening the study design. </plain></SENT>
<SENT sid="188" pm="."><plain>Nevertheless, the academic literature indicates that PA status of COPD patients a few months and 1 year after PR is unlikely to differ [35, 36]. </plain></SENT>
<SENT sid="189" pm="."><plain>If the inexpensive, pedometer-based intervention proves its effectiveness it may be easily applied to similar inpatient rehabilitation programs. </plain></SENT>
<SENT sid="190" pm="."><plain>These findings may then also apply to other clinical populations. </plain></SENT>
</text></p><p id="Par55"><text><SENT sid="191" pm="."><plain>Furthermore, the study generates a better understanding as to why patients with COPD manage or fail to initiate and maintain PA after PR. </plain></SENT>
<SENT sid="192" pm="."><plain>Based on the concepts from the model of PA-related health competence (PARC model) [7, 24] an adequate setup of individual physical and psychological determinants of PA will be assessed. </plain></SENT>
<SENT sid="193" pm="."><plain>The diagnostic battery will enrich our understanding of why the pedometer-based intervention works. </plain></SENT>
<SENT sid="194" pm="."><plain>In particular, the PA-related regulation competence is expected to contribute to this explanation of the intervention treatment effect. </plain></SENT>
<SENT sid="195" pm="."><plain>Furthermore, the results of a cluster-based analysis enable, regardless of the randomly controlled pedometer intervention’s effectiveness, the future identification of patients with COPD who will find it difficult to engage in long-term, health-promoting PA after PR. </plain></SENT>
<SENT sid="196" pm="."><plain>Acquiring a valid model for the prediction of PA behavior is the basis for optimizing intervention strategies to promote PA in the context of PR. </plain></SENT>
</text></p></sec></SecTag><sec id="Sec24"><title><text><SENT sid="197" pm="."><plain>Trial status </plain></SENT>
</text></title><p id="Par56"><text><SENT sid="198" pm="."><plain>The STAR study started in June 2016 and completion of recruitment is estimated for September. </plain></SENT>
</text></p></sec><sec sec-type="supplementary-material"><title><text><SENT sid="199" pm="."><plain>Additional files </plain></SENT>
</text></title><sec id="Sec25"><p><text><SENT sid="200" pm="."><plain>Additional file 1:Promoting physical activity: behavior change techniques used during Pulmonary Rehabilitation standard care in the Clinic Bad Reichenhall. </plain></SENT>
<SENT sid="201" pm="."><plain>(DOCX 15 kb) Additional file 2:Content of the two lessons of the pedometer-based physical activity (PA) behavior-change interventions (BCI) classified with the taxonomy of behavior change techniques from Michie et al. [11]. </plain></SENT>
<SENT sid="202" pm="."><plain>(DOCX 17 kb) Additional file 3:SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents. </plain></SENT>
<SENT sid="203" pm="."><plain>(DOC 102 kb) </plain></SENT>
</text></p></sec></sec></body><back><SecTag type="ABBR"><glossary><title>Abbreviations</title><def-list><def-item><term>BCI</term><def><p id="Par6">Behavior-change intervention</p></def></def-item><def-item><term>BCT</term><def><p id="Par7">Behavior-change technique</p></def></def-item><def-item><term>CG</term><def><p id="Par8">Control group</p></def></def-item><def-item><term>COPD</term><def><p id="Par9">Chronic obstructive pulmonary disease</p></def></def-item><def-item><term>IG</term><def><p id="Par10">Intervention group</p></def></def-item><def-item><term>PA</term><def><p id="Par11">Physical activity</p></def></def-item><def-item><term>PARC model</term><def><p id="Par12">Physical Activity-related health Competence model</p></def></def-item><def-item><term>PR</term><def><p id="Par13">Pulmonary rehabilitation</p></def></def-item></def-list></glossary></SecTag><fn-group><fn><p><text><SENT sid="204" pm="."><plain>Electronic supplementary material </plain></SENT>
</text></p><p><text><SENT sid="205" pm="."><plain>The online version of this article (doi:10.1186/s13063-017-2124-z) contains supplementary material, which is available to authorized users. </plain></SENT>
</text></p></fn></fn-group><SecTag type="COMP_INT"><ack><title>Acknowledgements</title><p>The authors thank the German Pension Insurance Association, Section Bavaria South (Deutsche Rentenversicherung Bayern Süd), which sponsors and supports this study. We thank Amone Leithäusser who is the head of the section physical therapy, and the entire team of physical therapists, the study nurses Stephanie Häusl, Andrea Klotz, Maike Messerschmidt, Berta Obermaier and the recruiting physicians of the Bad Reichenhall Clinic for their outstanding engagement. We further thank Samuel Cassar for the language revision of this manuscript. We acknowledge support from the Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) within the funding program Open Access Publishing.</p><sec id="FPar1"><title>Funding</title><p id="Par57">This study is founded by the German Pension Insurance Association, Section Bavaria South (Deutsche Rentenversicherung Bayern Süd; Abteilung Rehabilitation und Sozialmedizin, Am Alten Viehmarkt 2, 84028 Landshut, Germany) (Reference number: 5.011-6.031.115) (<ext-link ext-link-type="uri" xlink:href="http://www.deutsche-rentenversicherung-bayernsued.de">www.deutsche-rentenversicherung-bayernsued.de</ext-link>) which was not involved in the design of the study and collection, management, analysis, interpretation of data, in writing the manuscript, or the decision to submit the report for publication.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par58">WG, KS, and KP will have access to the final trial dataset.</p></sec><sec id="FPar3"><title>Declarations</title><p id="Par59">The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) Statement is included as Additional file <xref rid="MOESM3" ref-type="media">3</xref>.</p></sec></ack></SecTag><SecTag type="SUPPL"><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>WG, KS, JS, RS, AT, NL, SW, MW, RW, and KP conceived and designed the study. NL and SW will be responsible for the delivering of the intervention. MW, RW, and KP will be responsible for the recruiting. WG, KS, and KP are the principal investigators and will analyze the data. WG wrote the paper. WG will respond to public and scientific queries. All authors edited, revised and approved the final manuscript.</p></notes></SecTag><notes notes-type="COI-statement"><sec id="FPar4"><title>Ethics approval and consent to participate</title><p id="Par60">The study protocol was approved by the independent Research Ethics Committee of the Medical Faculty of Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany in 2015 (Ref. No. 321_15B).</p><p id="Par61">The Department of Data Privacy Collection of the German Pension Insurance Association, Section Bavaria South approved the STAR study data security model to ensure confidentiality before, during, and after the trial. Signed informed consent of the participants is a prerequisite for taking part in the STAR study.</p></sec><sec id="FPar5"><title>Consent for publication</title><p id="Par62">Not applicable</p></sec><sec id="FPar6"><title>Competing interests</title><p id="Par63">The authors declare that they have no competing interests.</p></sec><sec id="FPar7"><title>Publisher’s Note</title><p id="Par64">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><SecTag type="REF"><ref-list id="Bib1"><title>References</title><ref id="CR1"><text><SENT sid="206" pm="."><plain>1.SpruitMASinghSJGarveyCZuWallackRNiciLRochesterCAn official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitationAm J Respir Crit Care Med2013188e136410.1164/rccm.201309-1634ST<?supplied-pmid 24127811?>24127811 </plain></SENT>
</text></ref><ref id="CR2"><text><SENT sid="207" pm="."><plain>2.BusbyAKReeseRLSimonSRPulmonary rehabilitation maintenance interventions: a systematic reviewAm J Health Behav2014383213010.5993/AJHB.38.3.1<?supplied-pmid 24636028?>24636028 </plain></SENT>
</text></ref><ref id="CR3"><text><SENT sid="208" pm="?"><plain>3.NgLWCMackneyJJenkinsSHillKDoes exercise training change physical activity in people with COPD? </plain></SENT>
<SENT sid="209" pm="."><plain>A systematic review and meta-analysisChron Respir Dis20129172610.1177/147997231143033522194629 </plain></SENT>
</text></ref><ref id="CR4"><text><SENT sid="210" pm="."><plain>4.SpruitMAPittaFMcAuleyEZuwallackRLNiciLPulmonary rehabilitation and physical activity in patients with COPDAm J Respir Crit Care Med20151929243310.1164/rccm.201505-0929CI<?supplied-pmid 26161676?>26161676 </plain></SENT>
</text></ref><ref id="CR5"><text><SENT sid="211" pm="."><plain>5.Gimeno-SantosEFreiASteurer-SteyCde BatlleJRabinovichRARasteYDeterminants and outcomes of physical activity in patients with COPD: a systematic reviewThorax201469731910.1136/thoraxjnl-2013-204763<?supplied-pmid 24558112?>24558112 </plain></SENT>
</text></ref><ref id="CR6"><text><SENT sid="212" pm="."><plain>6.AltenburgWAten HackenNHTBossenbroekLKerstjensHAde GreefMHGWempeJBShort- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trialRespir Med20151091122110.1016/j.rmed.2014.10.020<?supplied-pmid 25499548?>25499548 </plain></SENT>
</text></ref><ref id="CR7"><text><SENT sid="213" pm="."><plain>7.SudeckGPfeiferKPhysical activity-related health competence as an integrative objective in exercise therapy and health sports—conception and validation of a short questionnaireSportwiss201646748710.1007/s12662-016-0405-4 </plain></SENT>
</text></ref><ref id="CR8"><text><SENT sid="214" pm="."><plain>8.HeathGWParraDCSarmientoOLAndersenLBOwenNGoenkaSEvidence-based intervention in physical activity: lessons from around the worldLancet20123802728110.1016/S0140-6736(12)60816-2<?supplied-pmid 22818939?>22818939 </plain></SENT>
</text></ref><ref id="CR9"><text><SENT sid="215" pm="."><plain>9.KoringMParschauLLangeDFleigLKnollNSchwarzerRPreparing for physical activity: pedometer acquisition as a self-regulatory strategyAppl Psychol Health Well Being201351364710.1111/aphw.12003<?supplied-pmid 23457088?>23457088 </plain></SENT>
</text></ref><ref id="CR10"><text><SENT sid="216" pm="."><plain>10.ConnVSHafdahlARBrownSABrownLMMeta-analysis of patient education interventions to increase physical activity among chronically ill adultsPatient Educ Couns2008701577210.1016/j.pec.2007.10.004<?supplied-pmid 18023128?>18023128 </plain></SENT>
</text></ref><ref id="CR11"><text><SENT sid="217" pm="."><plain>11.MichieSRichardsonMJohnstonMAbrahamCFrancisJHardemanWThe behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventionsAnn Behav Med201346819510.1007/s12160-013-9486-6<?supplied-pmid 23512568?>23512568 </plain></SENT>
</text></ref><ref id="CR12"><text><SENT sid="218" pm="."><plain>12.KangMMarshallSJBarreiraTVLeeJEffect of pedometer-based physical activity interventions: a meta-analysisRes Q Exerc Sport20098064855<?supplied-pmid 19791652?>19791652 </plain></SENT>
</text></ref><ref id="CR13"><text><SENT sid="219" pm="."><plain>13.MansiSMilosavljevicSBaxterGTumiltySHendrickPA systematic review of studies using pedometers as an intervention for musculoskeletal diseasesBMC Musculoskelet Disord20141523110.1186/1471-2474-15-231<?supplied-pmid 25012720?>25012720 </plain></SENT>
</text></ref><ref id="CR14"><text><SENT sid="220" pm="."><plain>14.FunkMLaurette-TaylorEPedometer-based walking interventions for free-living adults with type 2 diabetes: a systematic reviewCurr Diabetes Rev201394627110.2174/15733998113096660084<?supplied-pmid 24160358?>24160358 </plain></SENT>
</text></ref><ref id="CR15"><text><SENT sid="221" pm="."><plain>15.Mendoza L, Horta P, Espinoza J, Aguilera M, Balmaceda N, Castro A, et al. </plain></SENT>
<SENT sid="222" pm="."><plain>Pedometers to enhance physical activity in COPD: a randomised controlled trial. </plain></SENT>
<SENT sid="223" pm="."><plain>Eur Respir J. </plain></SENT>
<SENT sid="224" pm="."><plain>2014. doi:10.1183/09031936.00084514. </plain></SENT>
</text></ref><ref id="CR16"><text><SENT sid="225" pm="."><plain>16.BerticiNFira-MlǎdinescuOOanceaCTudoracheVThe usefulness of pedometry in patients with chronic obstructive pulmonary diseaseMultidiscip Respir Med201381710.1186/2049-6958-8-7<?supplied-pmid 23384150?>23384150 </plain></SENT>
</text></ref><ref id="CR17"><text><SENT sid="226" pm="."><plain>17.SinghSMorganMOne step beyond, does rehabilitation influence physical activity?Chron Respir Dis201293410.1177/1479972311432354<?supplied-pmid 22308548?>22308548 </plain></SENT>
</text></ref><ref id="CR18"><text><SENT sid="227" pm="."><plain>18.VestboJHurdSSAgustíAGJonesPWVogelmeierCAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summaryAm J Respir Crit Care Med20131873476510.1164/rccm.201204-0596PP<?supplied-pmid 22878278?>22878278 </plain></SENT>
</text></ref><ref id="CR19"><text><SENT sid="228" pm="."><plain>19.FischerJSchnabelMSitterHRehabilitation of patients with chronic obstructive pulmonary disease (COPD) S2 guideline of the German Society for Pneumology and Respiratory Medicine and the German Society for Rehabilitation Science (RGRW)Pneumologie2007612334810.1055/s-2007-959196<?supplied-pmid 17455138?>17455138 </plain></SENT>
</text></ref><ref id="CR20"><text><SENT sid="229" pm="."><plain>20.WilsonJJO’NeillBCollinsEGBradleyJInterventions to increase physical activity in patients with COPD: a comprehensive review: COPD: Journal of Chronic Obstructive Pulmonary DiseaseCOPD2015123324310.3109/15412555.2014.948992<?supplied-pmid 25221907?>25221907 </plain></SENT>
</text></ref><ref id="CR21"><text><SENT sid="230" pm="."><plain>21.RabinovichRALouvarisZRasteYLangerDvan RemoortelHGiavedoniSValidity of physical activity monitors during daily life in patients with COPDEur Respir J20134212051510.1183/09031936.00134312<?supplied-pmid 23397303?>23397303 </plain></SENT>
</text></ref><ref id="CR22"><text><SENT sid="231" pm="."><plain>22.van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al. </plain></SENT>
<SENT sid="232" pm="."><plain>Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. </plain></SENT>
<SENT sid="233" pm="."><plain>PLoS One 2012;7. doi:10.1371/journal.pone.0039198. </plain></SENT>
</text></ref><ref id="CR23"><text><SENT sid="234" pm="."><plain>23.StrathSJPfeifferKAWhitt-GloverMCAccelerometer use with children, older adults, and adults with functional limitationsMed Sci Sports Exerc201244S778510.1249/MSS.0b013e3182399eb1<?supplied-pmid 22157778?>22157778 </plain></SENT>
</text></ref><ref id="CR24"><text><SENT sid="235" pm="."><plain>24.Pfeifer K, Sudeck G, Geidl W, Tallner A. </plain></SENT>
<SENT sid="236" pm="."><plain>Bewegungsförderung und Sport in der Neurologie – Kompetenzorientierung und Nachhaltigkeit. </plain></SENT>
<SENT sid="237" pm="."><plain>Neurol Rehabil. </plain></SENT>
<SENT sid="238" pm="."><plain>2013;19;1;7–19. </plain></SENT>
</text></ref><ref id="CR25"><text><SENT sid="239" pm="."><plain>25.Bergman LR, Wångby M. </plain></SENT>
<SENT sid="240" pm="."><plain>The person-oriented approach. </plain></SENT>
<SENT sid="241" pm="."><plain>A short theoretical and practical guide. </plain></SENT>
<SENT sid="242" pm="."><plain>Est J Educat. </plain></SENT>
<SENT sid="243" pm="."><plain>2014;2. doi:10.12697/eha.2014.2.1.02b </plain></SENT>
</text></ref><ref id="CR26"><text><SENT sid="244" pm="."><plain>26.MatthewsCEHagströmerMPoberDMBowlesHRBest practices for using physical activity monitors in population-based researchMed Sci Sports Exerc201244S687610.1249/MSS.0b013e3182399e5b<?supplied-pmid 22157777?>22157777 </plain></SENT>
</text></ref><ref id="CR27"><text><SENT sid="245" pm="."><plain>27.PedišićZBaumanAAccelerometer-based measures in physical activity surveillance: Current practices and issuesBr J Sports Med2015492192310.1136/bjsports-2013-093407<?supplied-pmid 25370153?>25370153 </plain></SENT>
</text></ref><ref id="CR28"><text><SENT sid="246" pm="."><plain>28.ThielCGabrysLVogtLMeasuring physical activity with wearable accelerometersDtsch Z Sportmed20166744810.5960/dzsm.2016.220 </plain></SENT>
</text></ref><ref id="CR29"><text><SENT sid="247" pm="."><plain>29.GormanEHansonHMYangPHKhanKMLiu-AmbroseTAsheMCAccelerometry analysis of physical activity and sedentary behavior in older adults: a systematic review and data analysisEur Rev Aging Phys Act201411354910.1007/s11556-013-0132-x<?supplied-pmid 24765212?>24765212 </plain></SENT>
</text></ref><ref id="CR30"><text><SENT sid="248" pm="."><plain>30.van RemoortelHCamilloCALangerDHornikxMDemeyerHBurtinCModerate intense physical activity depends on selected metabolic equivalent of task (MET) cut-off and type of data analysisPLoS One20138e8436510.1371/journal.pone.0084365<?supplied-pmid 24376804?>24376804 </plain></SENT>
</text></ref><ref id="CR31"><text><SENT sid="249" pm="."><plain>31.EvensonKRWenFMetzgerJSHerringAHPhysical activity and sedentary behavior patterns using accelerometry from a national sample of United States adultsInt J Behav Nutr Phys Act2015122010.1186/s12966-015-0183-7<?supplied-pmid 25889192?>25889192 </plain></SENT>
</text></ref><ref id="CR32"><text><SENT sid="250" pm="."><plain>32.WallénMBNeroHFranzénEHagströmerMComparison of two accelerometer filter settings in individuals with Parkinson’s diseasePhysiol Meas20143522879610.1088/0967-3334/35/11/2287<?supplied-pmid 25340812?>25340812 </plain></SENT>
</text></ref><ref id="CR33"><text><SENT sid="251" pm="."><plain>33.KorpanSMSchaferJLWilsonKWebberSCEffect of actigraph GT3X+ position and algorithm choice on step count accuracy in older adultsJ Aging Phys Act2015233778210.1123/japa.2014-0033<?supplied-pmid 25102469?>25102469 </plain></SENT>
</text></ref><ref id="CR34"><text><SENT sid="252" pm="."><plain>34.LeeIShiromaEJUsing accelerometers to measure physical activity in large-scale epidemiological studies: issues and challengesBr J Sports Med20144819720110.1136/bjsports-2013-093154<?supplied-pmid 24297837?>24297837 </plain></SENT>
</text></ref><ref id="CR35"><text><SENT sid="253" pm="."><plain>35.SoicherJMayoEGauvinLHanleyJBernardSMaltaisFTrajectories of endurance activity following pulmonary rehabilitation in COPD patientsEur Respir J201239272810.1183/09031936.00026011<?supplied-pmid 21737565?>21737565 </plain></SENT>
</text></ref><ref id="CR36"><text><SENT sid="254" pm="."><plain>36.SaundersTDechmanGHernandezPSpenceJRhodesRMcGannonKDistinct trajectories of physical activity among patients with COPD during and after pulmonary rehabilitationCOPD2015125394510.3109/15412555.2014.995286<?supplied-pmid 25774558?>25774558 </plain></SENT>
</text></ref><ref id="CR37"><text><SENT sid="255" pm="."><plain>37.FuchsRKlaperskiSGerberMSeeligHMessung der Bewegungs- und Sportaktivität mit dem BSA-FragebogenZ Gesundheitspsychol201523607610.1026/0943-8149/a000137 </plain></SENT>
</text></ref><ref id="CR38"><text><SENT sid="256" pm="."><plain>38.CelliBRCoteCGMarinJMCasanovaCMontes De OcaMMendezRAThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med200435010051210.1056/NEJMoa021322<?supplied-pmid 14999112?>14999112 </plain></SENT>
</text></ref><ref id="CR39"><text><SENT sid="257" pm="."><plain>39.PuhanMAGarcia-AymerichJFreyMter RietGAntóJMAgustíAGExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE Index and the ADO IndexLancet20093747041110.1016/S0140-6736(09)61301-5<?supplied-pmid 19716962?>19716962 </plain></SENT>
</text></ref><ref id="CR40"><text><SENT sid="258" pm="."><plain>40.MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea. </plain></SENT>
<SENT sid="259" pm="."><plain>Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest198485751810.1378/chest.85.6.751<?supplied-pmid 6723384?>6723384 </plain></SENT>
</text></ref><ref id="CR41"><text><SENT sid="260" pm="."><plain>41.KühlKKuhnCKennKRiefWDer COPD-Angst-Fragebogen (CAF): Ein neues Instrument zur Erfassung krankheitsspezifischer Ängste bei COPD-PatientenPsychother Psychosom Med Psychol201161e1910.1055/s-0030-1248281<?supplied-pmid 20401826?>20401826 </plain></SENT>
</text></ref><ref id="CR42"><text><SENT sid="261" pm="."><plain>42.LöweBSpitzerRZipfelSHerzogWGesundheitsfragebogen für Patienten (PHQ D). </plain></SENT>
<SENT sid="262" pm="."><plain>Komplettversion und Kurzform. </plain></SENT>
<SENT sid="263" pm="."><plain>Testmappe mit Manual, Fragebögen, Schablonen. </plain></SENT>
<SENT sid="264" pm="."><plain>2. </plain></SENT>
<SENT sid="265" pm="."><plain>Auflage2002KarlsruhePfizer </plain></SENT>
</text></ref><ref id="CR43"><text><SENT sid="266" pm="."><plain>43.JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. </plain></SENT>
<SENT sid="267" pm="."><plain>The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921451321710.1164/ajrccm/145.6.1321<?supplied-pmid 1595997?>1595997 </plain></SENT>
</text></ref><ref id="CR44"><text><SENT sid="268" pm="."><plain>44.ArdeleanDLIuliaLPopescuRDidilescuCDinescuSOlteanuMNituMEvaluation of COPD patients using CAT-COPD assessment testPneumologia2012612219<?supplied-pmid 23424946?>23424946 </plain></SENT>
</text></ref><ref id="CR45"><text><SENT sid="269" pm="."><plain>45.BluemkeMFrieseMReliability and validity of the Single-Target IAT (ST-IAT): assessing automatic affect towards multiple attitude objectsEur J Soc Psychol2008389779710.1002/ejsp.487 </plain></SENT>
</text></ref><ref id="CR46"><text><SENT sid="270" pm="."><plain>46.Huber G, Sudeck G. </plain></SENT>
<SENT sid="271" pm="."><plain>Entwicklung einer person-orientierten Bewegungstherapie in der medizinischen Rehabilitation. </plain></SENT>
<SENT sid="272" pm="."><plain>Unveröffentlichter Abschlussbericht des von der Deutschen Rentenversicherung Bund geförderten Projektes Nr. </plain></SENT>
<SENT sid="273" pm="."><plain>0422-40-64-50-16; available online: <ext-link ext-link-type="uri" xlink:href="http://forschung.deutsche-rentenversicherung.de/ForschPortalWeb/ressource?key=Final2014_Abschlussbericht_PersonOrientierteBewegungstherapie.pdf">http://forschung.deutsche-rentenversicherung.de/ForschPortalWeb/ressource?key=Final2014_Abschlussbericht_PersonOrientierteBewegungstherapie.pdf</ext-link> </plain></SENT>
</text></ref><ref id="CR47"><text><SENT sid="274" pm="."><plain>47.SeeligHFuchsRMessung der sport- und bewegungsbezogenen SelbstkonkordanzZ Sportpsychol2006131213910.1026/1612-5010.13.4.121 </plain></SENT>
</text></ref><ref id="CR48"><text><SENT sid="275" pm="."><plain>48.BrandRDie affektive Einstellungskomponente und ihr Beitrag zur Erklärung von SportpartizipationZ Sportpsychol2006131475510.1026/1612-5010.13.4.147 </plain></SENT>
</text></ref><ref id="CR49"><text><SENT sid="276" pm="."><plain>49.Stenzel N, Rief W, Kenn K. </plain></SENT>
<SENT sid="277" pm="?"><plain>Fear Avoidance—Eine bedeutsame Aktivitätsbremse bei chronisch obstruktiver Lungenerkrankung (COPD)? </plain></SENT>
<SENT sid="278" pm="."><plain>Vortrag präsentiert auf dem 54. </plain></SENT>
<SENT sid="279" pm="."><plain>Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP), Hannover. </plain></SENT>
<SENT sid="280" pm="."><plain>2013. </plain></SENT>
</text></ref><ref id="CR50"><text><SENT sid="281" pm="."><plain>50.SolomonBKWilsonKGHendersonPRPoulinPAKowalJMcKimDAA breathlessness catastrophizing scale for chronic obstructive pulmonary diseaseJ Psychosom Res20157962810.1016/j.jpsychores.2014.11.020<?supplied-pmid 25498317?>25498317 </plain></SENT>
</text></ref><ref id="CR51"><text><SENT sid="282" pm="."><plain>51.RuppelGLEnrightPLPulmonary function testingRespir Care2012571657510.4187/respcare.01640<?supplied-pmid 22222135?>22222135 </plain></SENT>
</text></ref><ref id="CR52"><text><SENT sid="283" pm="."><plain>52.JonesSEKonSSCCanavanJLPatelMSClarkALNolanCMThe five-repetition sit-to-stand test as a functional outcome measure in COPDThorax20136810152010.1136/thoraxjnl-2013-203576<?supplied-pmid 23783372?>23783372 </plain></SENT>
</text></ref><ref id="CR53"><text><SENT sid="284" pm="."><plain>53.GerlachALAndorTPatzeltJDie Bedeutung von Unsicherheitsintoleranz für die Generalisierte Angststörung Modellüberlegungen und Entwicklung einer deutschen Version der Unsicherheitsintoleranz-SkalaZ Klin Psychol Psychother200837190910.1026/1616-3443.37.3.190 </plain></SENT>
</text></ref><ref id="CR54"><text><SENT sid="285" pm="."><plain>54.CarletonRNNortonMPJAsmundsonGJFearing the unknown. </plain></SENT>
<SENT sid="286" pm="."><plain>A short version of the intolerance of uncertainty scaleJ Anxiety Disord2007211051710.1016/j.janxdis.2006.03.014<?supplied-pmid 16647833?>16647833 </plain></SENT>
</text></ref><ref id="CR55"><text><SENT sid="287" pm="."><plain>55.GlaesmerHHoyerJKlotscheJHerzbergPYDie deutsche Version des Life-Orientation-Tests (LOT-R) zum dispositionellen Optimismus und PessimismusZ Gesundheitspsychol200816263110.1026/0943-8149.16.1.26 </plain></SENT>
</text></ref><ref id="CR56"><text><SENT sid="288" pm="."><plain>56.ScheierMFCarverCSBridgesMWDistinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the life orientation testJ Pers Soc Psychol19946710637810.1037/0022-3514.67.6.1063<?supplied-pmid 7815302?>7815302 </plain></SENT>
</text></ref><ref id="CR57"><text><SENT sid="289" pm="."><plain>57.Deck R, Röckelein. </plain></SENT>
<SENT sid="290" pm="."><plain>Zur Erhebung soziodemographischer und sozialmedizinischer Indikatoren in den rehabilitationswissenschaftlichen Forschungsverbünden. </plain></SENT>
<SENT sid="291" pm="."><plain>Förderschwerpunkt “Rehabilitationswissenschaften”. </plain></SENT>
<SENT sid="292" pm="."><plain>Empfehlungen der Arbeitsgruppen“Generische Methoden”, “Routinedaten” und “Reha-Ökonomie”. </plain></SENT>
<SENT sid="293" pm="."><plain>Verband Deutscher Rentenversicherungsträger (Hrsg.), Förderschwerpunkt “Rehabilitationswissenschaften”. </plain></SENT>
<SENT sid="294" pm="."><plain>Empfehlungen der Arbeitsgruppen “Generische Methoden”, “Routinedaten” und “Reha-Ökonomie”. </plain></SENT>
<SENT sid="295" pm="."><plain>DRV-Schriften. </plain></SENT>
<SENT sid="296" pm="."><plain>1999;16:84–102. </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
